Noradrenaline release and the effect of endogenous activation of the phospholipase C/protein kinase C signalling pathway in rat atria

British Journal of Pharmacology

Volumn 121, Issue 6, 1997, Pages 1196-1202

  Majewski, H ^a   Kotsonis, P ^a   Murphy, T V ^a   Barrington, M ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Diacylglycerol; Noradrenaline; Phospholipase C; Polymyxin B; Protein kinase C; R59949; Ro 318220; Sympathetic nerve; U73122

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3 [2 [4 (4,4' DIFLUOROBENZHYDRYLIDENE)PIPERIDINO]ETHYL] 2,3 DIHYDRO 2 THIOXO 4(1H) QUINAZOLINONE; NORADRENALIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PHOSPHOLIPASE D; POLYMYXIN B; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TRANSFERASE INHIBITOR; WORTMANNIN;

ANIMAL TISSUE; ARTICLE; ELECTROSTIMULATION; HEART ATRIUM; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE;

ANDROSTADIENES; ANIMALS; ATRIAL FUNCTION; DIACYLGLYCEROL KINASE; ELECTRIC STIMULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; ESTRENES; HEART ATRIA; MALE; NOREPINEPHRINE; PHOSPHOLIPASE C; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PIPERIDINES; PROTEIN KINASE C; PYRROLIDINONES; QUINAZOLINES; QUINAZOLINONES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 0030741622     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701236     Document Type: Article

References (37)

1. ALLGAIER, C. & HERTTING, G. (1986). Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12, 13-dibutyrate. Naunyn-Schmiedeberg's Arch. Pharmacol., 334, 218-221.
2. 2-autoreceptor modulated release of noradrenaline. Br. J. Pharmacol., 92, 161-172.
3. ARCARO, A. & WYMANN, M.P. (1993). Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J., 296, 297-301.
4. BLEASDALE, J.E., THAKUR, R.N., GREMBAN, R.S., BUNDY, G.L., FITZPATRICK, F.A., SMITH, R.J. & BUNTING, S. (1990). Selective inhibition of receptor coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther., 255, 756-768.
5. BONSER, R.W., THOMPSON, N.T., RANDALL, R.W., TATESON, J.E., SPACEY, G.D., HODSON, H.F. & GARLAND, L.G. (1991). Demothoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil. Br. J. Pharmacol., 103, 1237-1241.
6. BRASCH, H. (1991). Influence of phorbol esters on stimulation-induced noradrenaline release and contractile force of isolated guinea-pig atria. Basic Res. Cardiol., 86, 283-290.
7. BÜLTMANN, R., SZABO, B. & STARKE, K. (1993). Inhibition by ethanol of contractions of rat vas deferens: no evidence for selective blockade of P2X-purinoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 527-533.
8. CHALIFA, V., MÖHN, H. & LISCOVITCH, M. (1990). A neutral phospholipase D activity from rat brain synaptic plasma membranes. J. Biol. Chem., 265, 17512-17519.
9. 1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C. Br. J. Pharmacol., 110, 910-916.
10. COSTA, M. & MAJEWSKI, H. (1991). Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria. Br. J. Pharmacol., 102, 855-860.
11. DAVIS, P.D., ELLIOTT, L.H., HARRIS, W., HILL, C.H., HURST, S.A., KEECH, E., KUMAR, M.K., LAWTON, G., NIXON, J.S. & WILKINSON, S.E. (1992). Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J. Med. Chem., 35, 994-1001.
12. DE CHAFFOY DE COURCELLES, D. (1990). The use of diacylglycerol kinase inhibitors for elucidating the roles of protein kinase C. Adv. Second Messenger Phosphoprotein Res., 24, 491-496.
13. DE CHAFFOY DE COURCELLES, D., ROEVENS, P., VAN BELLE, H., KENNIS, L., SOMERS, Y. & DE CLERCK, F. (1989). The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using a novel diacylglycerol kinase inhibitor R 59 949. J. Biol. Chem., 264, 3274-3285.
14. FOUCART, S., MUSGRAVE, I.F. & MAJEWSKI, H. (1990). Inhibition of noradrenaline release by neuropeptide Y does not involve protein kinase C in mouse atria. Neuropeptides, 15, 179-185.
15. FOUCART, S., MUSGRAVE, I.F. & MAJEWSKI, H. (1991). Long term treatment with phorbol esters suggests a permissive role for protein kinase C in the enhancement of noradrenaline release. Mol. Neuropharmacol., 1, 95-101.
16. HAEFFNER, E.W. (1993). Diacylglycerol: formation and function in phospholipid-mediated signal transduction. Comp. Biochem. Physiol. C., 105, 337-345.
17. 2+ fluctuations and luteinizing hormone release can be uncoupled from inositol phosphate production. Endocrinology, 130, 3475-3483.
18. 3H]-noradrenaline. Br. J. Pharmacol., 94, 713-720.
19. KAHN, M.T. & MALIK, K.U. (1982). Modulation by prostaglandins of the release of [3H]noradrenaline evoked by potassium and nerve stimulation in the isolated heart. Eur. J. Pharmacol., 78, 213-218.
20. KANOH, H., YAMADA, K. & SAKANE, F. (1990). Diacylglycerol kinase: a key modulator of signal transduction? Trends Biochem. Sci., 15, 47-50.
21. LISCOVITCH, M. (1992). Crosstalk among multiple signal-activated phospholipases. Trends Biochem. Sci., 17, 393-399.
22. 2+ dependent protein kinase. Biochem. Biophys. Res. Commun., 109, 1129-1133.
23. MUSGRAVE, I.F., FOUCART, S. & MAJEWSKI, H. (1991). Evidence that angiotensin II enhances noradrenaline release from sympathetic nerves in mouse atria by activating protein kinase C. J. Autonom. Pharmacol., 11, 211-220.
24. MUSGRAVE, I.F. & MAJEWSKI, H. (1989). Effect of phorbol esters and polymyxin B on modulation of noradrenaline release in mouse atria. Naunyn-Schmiedeberg's Arch. Pharmacol., 339, 48-53.
25. NICHOLS, R.A., HAYCOCK, J.W., WANG, J.K.T. & GREENGARD, P. (1987). Phorbol ester enhancement of neurotransmitter release from rat brain synaptosomes. J. Neurochem., 48, 615-621.
26. NISHIZUKA, Y. (1992). Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science, 258, 607-614.
27. RÜEGG, U.T. & BURGESS, G.M. (1989). Staurosporine, K-252 and UCN-01: potent but non-specific inhibitors of protein kinases. Trends Pharmacol. Sci., 10, 218-220.
28. SCHÄCHTELE, C., RUDOLPH, C. & OSSWALD, H. (1989). Inhibition of protein kinase C (PKC) and three other protein kinases by several reference PKC inhibitors. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, R36.
29. SCHROEDER, G.E., KOTSONIS, P., MUSGRAVE, I.F. & MAJEWSKI, H. (1995). Protein kinase C involvement in maintenance and modulation of noradrenaline release in the mouse brain cortex. Br. J. Pharmacol., 116, 2757-2763.
30. SHUNTOH, H. & TANAKA, C. (1986). Activation of protein kinase C potentiates norepinephrine release from sinus node. Am. J. Physiol., 251, C833-C840.
31. SMART, D., WANDLESS, A. & LAMBERT, D.G. (1995). Activation of phospholipase C in SH-SY5Y neuroblastoma cells by potassium-induced calcium entry. Br. J. Pharmacol., 116, 1797-1800.
32. 1-adrenoceptors in negative feedback regulation of noradrenergic transmission in rat atria. Clin. Sci., 68 (suppl 10), 111s-115s.
33. THOMPSON, N.T., BONSER, R.W. & GARLAND, L.G. (1991). Receptor-coupled phospholipase D and its inhibition. Trends Pharmacol. Sci., 12, 404-407.
34. 3H] dopamine from amygdala slices in vitro: effects of 4β-phorbol 12, 13-dibutyrate, 4α-phorbol 12, 13-dideconate and polymyxin B. Brain Res., 416, 343-348.
35. WAKADE, A.R., MALHOTRA, R.K. & WAKADE, T.D. (1985). Phorbol ester, an activator of protein kinase C, enhances calcium-dependent release of sympathetic neurotransmitter. Naunyn-Schmiedeberg's Arch Pharmacol., 331, 122-124.
36. WAKADE, T.D., BHAVE, S.V., BHAVE, S.V., MALHOTRA, R.K. & WAKADE, A.R. (1991). Depolarizing stimuli and neurotransmitters utilize separate pathways to activate protein kinase C. Am. Soc. Biochem. Mol. Biol., 266, 6424-6428.
37. WATSON, S. & GIRDLESTONE, D. (1996). 1996 Receptor and ion channel nomenclature supplement. Trends Pharmacol. Sci., Suppl. 7.